Delivery Order SPE2DR25D6028-SPE2DR26FAQYK
Award Date 10/27/25
Potential Completion Date 10/28/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Levophed (norepinephrine) in 4 milliliter vials, quantity 10, with a ceiling value of $3,567.04 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for Levophed 4 mg/4 mL vials with a ceiling value of $1,334.19. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. This delivery order...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $1,051.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Levophed (norepinephrine) intravenous solution, 4mL vials in a 10-pack unit. The delivery order, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competitive, non-set-aside award. Levophed is a critical vasopressor medication used in emergency and intensive care settings to treat hypotension and maintain...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for Levophed SDV 4ML in quantities of 10, with a ceiling value of $3,076.85. This is a firm fixed price delivery order with an ultimate completion date of July 24, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,802.12 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Levophed (norepinephrine) in 4ml vials, a critical vasopressor medication used in emergency and intensive care settings. This firm fixed-price delivery order, with a completion date of September 29, 2025, was competitively awarded without set-aside designation and will be performed at the contractor's corporate headquarters in...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $172 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 4561412888 LEVOPHED 4 MG/4 ML vials. The single day contract has a period of performance from July 5 to July 6, 2023 for delivery to a location in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this award was issued against an existing...
- The Defense Logistics Agency awarded a $463.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561312420 LEVOPHED 4 MG/4 ML VIAL 4ML. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by June 23, 2023 in support of the Defense Logistics Agency's medical supply chain responsibilities. No subcontractors or set aside designations were indicated. The funding agency is a component of the Department of Defense focused...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Norepinephrine 4 mg/250 mL in 0.9% sodium chloride solution, a critical vasoactive medication used in acute care and emergency medical settings. This firm fixed-price delivery order, valued at $2,165.76, represents a child contract under AmerisourceBergen's larger $999.99 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which runs...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $34,883.25 to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Leqvio 284 mg/1.5 mL syringes. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $16,438.36 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Norepinephrine 8 mg/250 ml in D5W 250 ml formulation, with an ultimate completion date of September 17, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is serving as the prime contractor through its...